0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Refining the genomic determinants underlying escape from X-chromosome inactivation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          X-chromosome inactivation (XCI) epigenetically silences one X chromosome in every cell in female mammals. Although the majority of X-linked genes are silenced, in humans 20% or more are able to escape inactivation and continue to be expressed. Such escape genes are important contributors to sex differences in gene expression, and may impact the phenotypes of X aneuploidies; yet the mechanisms regulating escape from XCI are not understood. We have performed an enrichment analysis of transcription factor binding on the X chromosome, providing new evidence for enriched factors at the transcription start sites of escape genes. The top escape-enriched transcription factors were detected at the RPS4X promoter, a well-described human escape gene previously demonstrated to escape from XCI in a transgenic mouse model. Using a cell line model system that allows for targeted integration and inactivation of transgenes on the mouse X chromosome, we further assessed combinations of RPS4X promoter and genic elements for their ability to drive escape from XCI. We identified a small transgenic construct of only 6 kb capable of robust escape from XCI, establishing that gene-proximal elements are sufficient to permit escape, and highlighting the additive effect of multiple elements that work together in a context-specific fashion.

          Related collections

          Most cited references61

          • Record: found
          • Abstract: found
          • Article: not found

          Genome engineering using the CRISPR-Cas9 system.

          Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1-2 weeks, and modified clonal cell lines can be derived within 2-3 weeks.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Measures of the Amount of Ecologic Association Between Species

            Lee Dice (1945)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Expanded encyclopaedias of DNA elements in the human and mouse genomes

              The human and mouse genomes contain instructions that specify RNAs and proteins and govern the timing, magnitude, and cellular context of their production. To better delineate these elements, phase III of the Encyclopedia of DNA Elements (ENCODE) Project has expanded analysis of the cell and tissue repertoires of RNA transcription, chromatin structure and modification, DNA methylation, chromatin looping, and occupancy by transcription factors and RNA-binding proteins. Here we summarize these efforts, which have produced 5,992 new experimental datasets, including systematic determinations across mouse fetal development. All data are available through the ENCODE data portal (https://www.encodeproject.org), including phase II ENCODE 1 and Roadmap Epigenomics 2 data. We have developed a registry of 926,535 human and 339,815 mouse candidate cis-regulatory elements, covering 7.9 and 3.4% of their respective genomes, by integrating selected datatypes associated with gene regulation, and constructed a web-based server (SCREEN; http://screen.encodeproject.org) to provide flexible, user-defined access to this resource. Collectively, the ENCODE data and registry provide an expansive resource for the scientific community to build a better understanding of the organization and function of the human and mouse genomes.
                Bookmark

                Author and article information

                Contributors
                Journal
                NAR Genom Bioinform
                NAR Genom Bioinform
                nargab
                NAR Genomics and Bioinformatics
                Oxford University Press
                2631-9268
                June 2023
                30 May 2023
                30 May 2023
                : 5
                : 2
                : lqad052
                Affiliations
                Department of Medical Genetics, University of British Columbia , Vancouver, British Columbia, Canada
                Department of Medical Genetics, University of British Columbia , Vancouver, British Columbia, Canada
                Centre for Molecular Medicine and Therapeutics at British Columbia Children's Hospital, University of British Columbia , Vancouver, British Columbia, Canada
                Department of Medical Genetics, University of British Columbia , Vancouver, British Columbia, Canada
                Centre for Molecular Medicine and Therapeutics at British Columbia Children's Hospital, University of British Columbia , Vancouver, British Columbia, Canada
                Department of Medical Genetics, University of British Columbia , Vancouver, British Columbia, Canada
                Centre for Molecular Medicine and Therapeutics at British Columbia Children's Hospital, University of British Columbia , Vancouver, British Columbia, Canada
                Department of Medical Genetics, University of British Columbia , Vancouver, British Columbia, Canada
                Centre for Molecular Medicine and Therapeutics at British Columbia Children's Hospital, University of British Columbia , Vancouver, British Columbia, Canada
                Department of Medical Genetics, University of British Columbia , Vancouver, British Columbia, Canada
                Author notes
                To whom correspondence should be addressed. Tel: +1 604 822 0908; Email: carolyn.brown@ 123456ubc.ca
                Author information
                https://orcid.org/0000-0002-5969-3054
                https://orcid.org/0000-0001-6098-6412
                https://orcid.org/0000-0002-8959-0101
                Article
                lqad052
                10.1093/nargab/lqad052
                10227363
                fcf90f8b-0dca-4a3c-9ce4-6cca95027db1
                © The Author(s) 2023. Published by Oxford University Press on behalf of NAR Genomics and Bioinformatics.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License ( https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@ 123456oup.com

                History
                : 01 February 2023
                : 01 May 2023
                : 19 May 2023
                Page count
                Pages: 15
                Funding
                Funded by: Natural Sciences and Engineering Research Council of Canada, DOI 10.13039/501100000038;
                Award ID: RGPIN-2017-06824
                Funded by: Canadian Institutes of Health Research, DOI 10.13039/501100000024;
                Award ID: PJT-16120
                Categories
                AcademicSubjects/SCI00030
                AcademicSubjects/SCI00980
                AcademicSubjects/SCI01060
                AcademicSubjects/SCI01140
                AcademicSubjects/SCI01180
                Standard Article
                Editor's Choice

                Comments

                Comment on this article